TABLE 4

Individual baseline and functional outcomes^# at the end of follow-up

Patient identifier	Dose n cells	Baseline FVC %	Baseline D_LCO %	Functional outcome at 3 months	Last visit	Overall outcome at last visit/ or follow-up contact	Observations: death/lung transplant^¶
01_01	10×10⁶	53	35	Progression	6 months	Progression
01_03	10×10⁶	74	35	Stable	3 months	Other	Lung transplant at 6 months
01_05	10×10⁶	124	67	Stable	12 months	Stable
01_06	50×10⁶	57	42	Stable	9 months	Progression
01_07	50×10⁶	87	78	Progression	12 months	Stable
02_01	50×10⁶	64	51	Progression	12 months	Progression
01_09	100×10⁶	73	42	Progression	3 months	Other	Death at 5 months
01_10	100×10⁶	61	35	Stable	9 months	Progression
01_11	100×10⁶	96	53	Stable	12 months	Stable
01_13	100×10⁶	90	47	Progression	12 months	Progression
01_14	100×10⁶	52	39	Stable	6 months	Other	Death at 8 months
01_15	100×10⁶	69	43	Progression	3 months	Other	Death at 9 months
01_17	100×10⁶	83	43	Progression	12 months	Progression

FVC: forced vital capacity; D_LCO: diffusing capacity of the lung for carbon monoxide. ^#: progression defined by fall in FVC ≥10% and/or fall in D_LCO ≥15%, otherwise considered stable; ^¶: causes of death: 01_09 Legionella pneumonia, 01_14 IPF progression, 01_15 not determined.